Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03939026 |
|---|---|
| Brief Title: | Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma (ALPHA) |
| First Submitted : | April 4, 2019 |
| First Submitted that Met QC Criteria : | May 3, 2019 |
| First Posted : | May 6, 2019 |
| Last Update Submitted that Met QC Criteria : | May 25, 2022 |
| Last Update Posted : | May 26, 2022 |